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chologic battery to accurately evaluate cognitive effects of microemboli.
Disclosure:The content was partially presented as a poster in Human
Brain Imaging 2009.
Contemporary Management of Aberrant Right Subclavian Arteries
William M. Stone, MD, Joseph J. Ricotta, II, MD, Richard J. Fowl, MD,
Thomas C. Bower,MD, and Samuel R.Money,MD,Dept of Surgery,Mayo
Clinic Arizona, Scottsdale, AZ, Rochester, MN, and Scottsdale, AZ
Background:Aberrant origin of right subclavian arteries represents the
most common of the aortic arch anomalies. This variant has few published
series to guide management. Our goal was to review treatment options and
results for these potentially complex reconstructions.
Methods:A retrospective reviewwas performed on all patients with the
diagnosis of aberrant right subclavian artery at our institution from January
2003 through July 2009.
Results: Nineteen patients, comprising one of the largest series re-
ported, including 9 males and 10 females (mean age, 40.6 years; range,
7-77), were diagnosed with an aberrant right subclavian artery. The diag-
nosis was incidental in 14 (74%), but 5 (26%) had symptoms of dysphagia or
upper extremity ischemia, or both. The diagnosis was established by com-
puted tomography in 15 patients (79%), by magnetic resonance imaging in
3 (15%), and by standard angiography in 1 (5%). The most common
associated anomaly was a Kommerell’s diverticulum (KD), which was found
in five patients (26%), all of whom required intervention for symptoms or
aneurysmal degeneration. Intervention was performed in 10 patients (53%),
including carotid subclavian bypass in 5 (50%), carotid subclavian transpo-
sition in 3 (30%), and ascending aorta to subclavian bypass in 2 (20%). Four
patients (40%) had additional intervention for management of aneurysmal
disease of the aorta or KD, with open aortic replacement in two (20%) and
aortic endografting in two (20%). There was one perioperative death (10%)
in a patient undergoing aortic arch debranching with placement of an aortic
endograft. Eighteen patients were alive without symptoms after a mean
follow-up of 38 months.
Conclusions: Aberrant right subclavian arteries are most commonly
found incidentally with computed tomography. The presence of a KD
appeared to correlate with the need for intervention. Patients with no
symptoms with the absence of a KD can safely be followed.
Fig. Regions vulnerable to microemboli
Table. Patency, limb salvage, and survival rates
1 Mon (%) 3 Mon (%) 6
Primary 89.5 79.6
Primary assisted 91.5 82.2
Secondary 94.9 90.0
Limb salvage 96.3 92.7
Survival 96.7 89.9 86.1Clinical Outcomes and Implications of Failed Infrainguinal Endovas-
cular Stents
Ilia Gur, MD, William Lee, Fred A. Weaver, MD, Vincent L. Rowe, MD,
Gabriel Akopian, and Steven G. Katz, MD, Vascular Surgery, USC, Pasa-
dena, CA, Pasadena, CA, and Los Angeles, CA
Objective: Although the influence of initial TASC II classification has
been clearly shown to influence the primary patency of infrainguinal stenting
procedures, its effect on outcomes once stent failure has occurred is less well
documented. It is the objective of this paper to determine whether clinical
outcomes and implications of anatomic stent failure vary according to initial
TASC II classification
Methods:Results were analyzed by TASC II classification. Kaplan-
Meier survival curves were plotted, and differences between groups tested by
log-rank method. A Cox proportional hazards regression model was used to
perform the multivariate analysis
Results: During a 5-year period, 239 angioplasties and stents were
performed in 192 patients. Primary patency was lost in 69 stented arteries.
Failure was due to one or more hemodynamically significant stenoses in 43
patients and occlusion in 26. After primary stenting, limbs initially classified
as TASC C and D were more likely to fail with occlusion (P  .0001),
require open operation (P  .032), or lose runoff vessels (P  .0034) than
those classified as TASCA or B. In two patients initially classified as TASCC,
stent failure changed the level of the open operation to a more distal site.
Percutaneous reintervention was performed on 35 limbs. Successful reinterven-
tion improved the patency of TASC A and B lesions to 92%, 85%, and 64% and
TASC C and D lesions to 78%, 72%, and 50% at 12, 24, and 36 months,
respectively. Initial TASC classification was highly predictive of first anatomic
failure (P  .0001) but did not predict the durability of subsequent catheter
based reintervention (P .32). Ten patients with stent failure required opera-
tion, and five underwent amputation; all had failed with occlusion. Overall limb
salvage was 89% and periprocedural mortality was 0.4%.
Conclusions: After primary stenting of the SFA and popliteal artery,
lesions classified as TASC C or D are more likely to fail with occlusion, lose
runoff vessels, and alter the site of subsequent open operation than their
TASC A and B counterparts. Although these complications are infrequent,
they may negatively impact later attempts at revascularization and this must
be considered when deciding on the proper treatment strategy for patients
with infrainguinal occlusive disease.
Intraoperative Thrombolysis and Laser Atherectomy: Effective Treat-
ment for TASC C and D Lesions in Critical Limb Ischemia
Sam S. Ahn, MD, Kenneth R. Kollmeyer, MD, Foster A. Hays, Julia F.
Chen, Craig A. Ferrara, MD, Pablo V. Uceda, MD, and Robert W. Feldt-
man, MD, DFW Vascular Group, Dallas, TX, and Dallas, TX
Objective: We postulate that catheter-directed intraoperative throm-
bolysis in conjunction with laser atherectomy is a safe and effective treatment
of TASC C and D critical limb ischemia.
Methods: We retrospectively analyzed 411 patients who underwent
670 percutaneous, lower extremity interventions from September 2004 to
October 2009. Indications for intervention were limb salvage (98.7%) and
claudication (1.3%). TASC C lesions were present in 40.9% of patients and
TASC D lesions in 59.1%. Gender was 51.0% male and 49.0% female.
Average age was 69.5  12.0 years (range, 30-97 years). Risk factors
included hypertension (87.8%), diabetes (70.2%), coronary artery disease
(56.4%), tobacco abuse (54.8%), hyperlipidemia (49.4%), COPD (36.6%),
congestive heart failure (26.3%), renal insufficiency (23.7%), history of
myocardial infarction (21.3%), history of TIA or CVA (20.0%), atrial fibril-
lation (16.6%), dialysis (16.0%), morbid obesity (14.9%), arrhythmia (7.3%),
and pacemaker (6.1%). All procedures involved catheter-directed arterial
infusion of 2 to 10 mg of tissue plasminogen activator into the lesion and
laser atherectomy: 647 extremities required balloon angioplasty, and 326
extremities required stenting. Technical success required completion of the
intended procedure. Clinical success required no deaths, strokes, myocardial
infarctions, bleeding requiring transfusion, thromboemboli, infection, respi-
ratory complications, or reinterventions within 30 days. Follow-up was at 24
hours, 30 days, 6 months, and then every 6 months. Kaplan-Meier analysis
was used for patency, limb salvage, and survival rates.
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Within 30 days postoperatively, 6.2% required repeat intervention; 4.2% re-
quired amputation; 3.3% experienced postoperative complications, including
bleeding requiring transfusion (1.1%), thromboemboli (1.0%), infection
(0.7%), respiratory complications (0.4%), andmyocardial infarction (0.1%); and
3.3% died. Patency, limb salvage, and survival rates are listed in the Table.
Conclusions: The combination of thrombolysis and laser atherectomy
is safe and effective in treating TASC C and D lesions in this high-risk group
of patients with critical limb ischemia.
Deep Venous Thrombosis (DVT) in Critically Ill Trauma Patients:
There Are No Low Risk Patients
Amir F. Azarbal, MD, Susan Rowell, MD, Jason Lewis, Shannon Moseley,
Rakhee Urankar, MD, Erica Mitchell, MD, and Gregory L. Moneta, MD.
Oregon Health and Science University, Portland, OR
Objective: American Chest Physician (ACP) guidelines stratify DVT
risk in trauma patients based on injury pattern and medical prophylaxis.
Screening is recommended only for the highest risk groups. Many screening
studies for DVT have not investigated calf vein DVT (CVDVT) and did not
exclusively target critically ill patients. Given new ACP guidelines recom-
mending treatment of calf vein DVT, we investigated the efficacy of duplex
ultrasound (DUS) screening of critically ill trauma patients for all lower
extremity DVTs, including CVDVT, regardless of injury pattern, risk fac-
tors, or medical prophylaxis.
Methods: The records of 264 intensive care unit trauma patients who
receivedDUS screening for lower extremity DVTwere examined for data on
high-risk injuries, DVT risk factors, and LMWH prophylaxis.
Results: DUS screening found DVT in 40 patients (15.2%), of which
25 (62.5%) were CVDVT, and 30% of all DVTs were diagnosed1 week of
admission. Patients without high-risk injuries receiving LMWHhad a 13.5%
DVT rate, which did not differ significantly from the 19.7% DVT rate in
high-risk injury patients not receiving LMWH (P .667). Patients without
high-risk injuries who received LMWH had high rates of DVT, even
excluding other DVT risk factors.
Conclusions: Lower extremity DVT is common in critically ill trauma
patients, particularly in the first week after injury, regardless of injury pattern,
DVT risk factors, or medical prophylaxis. Previous studies have underesti-
mated DVT rates by not investigating CVDVTs. We recommend early DVT
screening of all critically ill trauma patients.
Endovenous Ablation of Incompetent Perforator Veins Is Effective
Treatment for Recalcitrant Venous Ulcers
Peter Lawrence, MD, Ali Alktaifi, MD, and David Rigberg, MD. UCLA
Vascular Surgery, Los Angeles, CA
Objectives: Endovenous closure of incompetent saphenous veins has
been reported to facilitate venous ulcer healing; however, there is little
information about the effectiveness of perforator ablation (PA) in healing
recalcitrant venous ulcers. We report our experience with PA with venous
ulcers unresponsive to prolonged compression therapy.
Methods: Patients with nonhealing venous ulcers of 3 months’
duration underwent duplex ultrasound imaging to assess their lower extrem-
ity venous system for incompetence of superficial, perforating, and deep
veins. Patients who had either no saphenous incompetence or persistent
ulcers after saphenous ablation underwent PA of incompetent perforating
veins 3 mm that demonstrated reflux; initial treatment was performed on
the perforator vein adjacent to the ulcer, with additional incompetent veins
treated if ulcer healing failed.
Results: Fifty-six ulcers with 74 associated incompetent perforating veins
were treated with PA in 44 patients with CEAP 4 (9%), 5 (6%), and 6 (85%)
recalcitrant venous ulcers. Treated incompetent perforator veins were located in
the medial ankle (67 %) and calf (33%). Initial success of PA, assessed by
postprocedure duplex ultrasound imaging, was 55 %; reported complications of
catheter site skin necrosis (0%), infection (0%), and nerve injury (0%) did not
occur. In 18% of patients, more than one procedure was required for perforator
closure; 73% had eventual successful perforator closure. Failure of perforator
closure occurred in 27% and was associated with intercurrent illness, patient
noncompliance, and patient death from unrelated causes. Of patients whose
ulcers healed, the healing occurred at a mean of 2.3 months; an average PA of
1.5 incompetent veins per ulcer were required for healing.
Conclusions: This experience demonstrates both the feasibility and
effectiveness of PA for a selected group of patients with venous ulcers who
fail conventional therapy with compression.
Early Results of a Highly Selective Algorithm for Surgery on Patients
with Neurogenic Thoracic Outlet Syndrome: A Prospective Analysis
Venita Chandra,MD, Cornelius Olcott, IV,MD, and Jason T. Lee. Division
of Vascular Surgery, Stanford University Medical Center, Stanford, CAObjective:Neurogenic thoracic outlet syndrome (nTOS) encompasses
a wide spectrum of disabling symptoms that are often vague and difficult todiagnose and treat. We developed and prospectively analyzed a treatment
algorithm for nTOS utilizing objective disability criteria, TOS-specific phys-
ical therapy, radiographic evaluation of the thoracic outlet, and selective
surgical decompression.
Methods: Patients treated for nTOS from 2000-2009 were reviewed
(n  84). In period 1, most patients were offered surgery with documenta-
tion of appropriate symptoms. A prospective observational study began in
2006 (period 2), aimed to determine which patients benefitted from surgical
intervention. Evaluation began with a validated QuickDASH (QD) quality-
of-life scale (0-100, 100worse) and duplex imaging of the thoracic outlet.
Patients then participated in physical therapy (PT) for 2 to 3 months and
were offered surgery if there was documented improvement in symptoms.
Results: In period 1, 34 patients underwent first rib resection (68%
female; mean age, 39; 18% athletes, 15% workers comp). In operated-on
patients undergoing duplex imaging, 40% showed compression of the
thoracic outlet on provocative positioning. Based on subjective improve-
ment of symptoms, 59% of patients at 6 months had a positive outcome. In
period 2, 50 consecutive patients were evaluated for nTOS (62% female;
mean age, 35.4; 36% athletes, 14% workers comp) with a mean pre-PT QD
score of 55.5. All patients were prescribed PT, and 21 (42%) were eventually
offered surgical decompression (SURG) based on compliance with PT,
interval improvement on QD score, and duplex compression of the thoracic
outlet. Differences between the SURG and non-SURG cohorts are reported
in the Table. At the 6-month follow-up, 93% of patients expressed symp-
tomatic improvement, with the mean postoperative QD score decreasing to
23.3 (P  .01)
Conclusions:This highly selective algorithm for nTOS surgery leads to
improvement in overall success rates documented subjectively and objec-
tively. Compliance with TOS-specific PT, improvement in QD scores after
PT, radiographic impingement, young age, and competitive athletics are
associated with improved surgical outcomes. Long-term studies will be
necessary to document sustained symptom relief and to determine who the
optimal surgical candidates are.
Table. Prospective analysis of 50 patients evaluated for
nTOS
Period 2
(n  50)
SURG
(n  21)
Non-SURG
(n  29) P
Age, y 27.9 40.9 .0002
Female 61.9% 62.0% NS
Competitive athlete 61.9% 17.2% .002
History of trauma 57.1% 17.2% .006
Worker compensation 9.5% 17.2% NS
Duplex obliteration
of thoracic outlet 75% 60.7% NS
Pre-PT QuickDASH 56.5 54.9 NS
Post-PT QuickDASH 49.3 48.4 NS
Improved after PT 76% 21% .001
Infraclavicular First Rib Resection for Focused and Effective Treat-
ment of Venous Thoracic Outlet Syndrome
Paul C. Johnston, MD, Michael S. Conte, MD, Charles M. Eichler, MD,
Linda M. Reilly, MD, and Darren B. Schneider, MD. Vascular Surgery,
University of California San Francisco, San Francisco, CA
Objective: Thoracic outlet decompression is an effective and durable
treatment for venous thoracic outlet syndrome (VTOS), but there is no con-
sensus regarding the optimal operative approach. Transaxillary, supraclavicular,
or paraclavicular approaches aremost commonly used, based largely on surgeon
preference. However, unlike other forms of thoracic outlet syndrome, the
pathology in VTOS is centered in the anteriorly located costoclavicular space.
Therefore, we have adopted a focused infraclavicular approach with intraoper-
ative venography that provides excellent access to the axillosubclavian veins and
the costoclavicular space for effective treatment of VTOS patients.
Methods: Between June 2005 and March 2010, 32 consecutive pa-
tients underwent infraclavicular thoracic outlet decompression. All patients
presented with symptomatic subclavian vein thrombosis, including 8 (25%)
with acute (14 days) and 24 (75%) with subacute or chronic (14 days)
thrombosis. Twenty-eight (88%) underwent catheter-directed thrombolysis
preoperatively, often before referral to our institution.
Results: Infraclavicular first rib resection and intraoperative venogra-
phy was technically successful in all patients. Adjunctive procedures included
balloon angioplasty in 19 (59%) and venous stent placement in 1 (3%). Four
patients with chronic vein occlusion or stenosis underwent partial division of
the manubrium, vein reconstruction (patch angioplasty in 2 and interposi-
tion bypass in 2), and temporary AV fistula creation. At discharge, 31
patients (97%) patients had patent veins.
